Ameresco's $6.7 Billion Backlog Can't Buy Back Trust It Just Torched

Here's a fun exercise: find another stock that put up a genuinely "transformational" quarter, watched shares rip 28-40% on the news, and then gave all of it back — plus more — inside three weeks. That's AMRC's August in a nutshell, and it's the kind of round trip that should make you suspicious of both the euphoria and the despair.

Let's rewind. On August 3, Ameresco reported Q2 2026 numbers that genuinely earned the "transformational" label management slapped on them: $515.5 million in revenue (+9% YoY), Power Infrastructure segment up 65%, gross margin recovering to 17.7% from 14.1% the prior quarter, and — the real headline — $1.2 billion in new data-center power-infrastructure awards in a single quarter. That pushed the awarded backlog to $4.42 billion and total backlog to a record $6.73 billion, up 32% year-over-year. Management reaffirmed full-year guidance and actually raised the EPS range to $1.15–$1.35. The stock did exactly what you'd expect and exploded higher.

Then the wheels came off. On August 19, Ameresco filed an 8-K disclosing the CFO's resignation — two days after a director had already resigned. Baird downgraded the stock to Neutral with a $32 price target that same window, and the shares sliced straight through the $25 support shelf like it wasn't there. As of today, AMRC sits at $20.97, flirting with multi-year lows, down roughly 26% for the week and 34% for the quarter. RSI at 37.5, price sitting below every major moving average (SMA50 -16.4%, SMA200 -27.7%). This isn't a dip. It's a trend, and a violent one.

So which Ameresco is real — the backlog machine or the balance sheet mess?

Honestly, both, and that's the uncomfortable truth the market is currently pricing. The bull case isn't hype. A $1.2 billion single-quarter haul of data-center power awards, in an environment where every hyperscaler on earth is scrambling for on-site generation, is a legitimate structural tailwind — not a one-off. The O&M backlog crossing $1.5 billion gives Ameresco a recurring-revenue cushion it didn't used to have. And the PEG of 0.3 against a fair-value estimate north of $40 versus a stock trading near $21 is the kind of dislocation that gets value investors' pulses up.

But the bear case isn't noise, either — it's the actual cash flow statement. Operating cash flow was -$107.2 million in Q2. Free cash flow was -$240.8 million after $133.6 million of capex, following a -$61.5 million FCF quarter in Q1. Total debt has climbed to $2.02 billion against just $138 million of cash, with debt-to-equity north of 1.6x. Layer on the previously flagged technical covenant defaults, and a CFO walking out the door sixteen days after the best quarter in company history stops looking like coincidence and starts looking like a person who saw something on the horizon they didn't want their name attached to. Maybe that's unfair to him. The market clearly doesn't think so.

Here's where I land: the $1.2 billion of new awards is backlog, not booked revenue — it converts over 6 to 24 months, and cancellation risk is real. The gap between "awarded" and "cash in the door" is exactly where a company with negative operating cash flow and covenant issues gets squeezed. That said, the insider tape is worth noting — CEO Sakellaris bought stock three separate times in early August, and a director dropped nearly $1 million on 8/10, both near current levels. That's not the behavior of executives bracing for a liquidity crisis. It's also not enough, on its own, to override a balance sheet that needs to either raise capital or lean hard on partners like Neogenyx to fund the very projects fueling the growth story.

The forecast models want you to believe this bounces hard off support — but the 1-week directional accuracy in this stock right now is worse than a coin flip, so treat any tidy price target with real skepticism.

Bottom line: AMRC is a legitimate AI-infrastructure story wrapped around a financing problem, trading at a price that already assumes the worst but hasn't yet priced in the best. That's not a stock to back up the truck on. It's a stock to nibble, watch the cash flow statement like a hawk next quarter, and let the balance sheet — not the backlog slide deck — tell you when it's safe to get loud.